Pharmacy

Rep. Greg Murphy, MD, R-N.C., has introduced a bill that would require out-of-pocket expenditures for drugs to count toward a patient’s maximum out-of-pocket and deductible. Patients are increasingly getting prescription medications through direct-to-patient platforms that offer lower out-of-pocket costs, especially…

Health systems are seeing measurable returns from pharmacy-led initiatives, including a more than 2% reduction in A1C levels and hundreds of incident fixes and system enhancements, according to executives across the U.S. Pharmacy leaders told Becker’s these gains are being…

Vertical integration across insurers, pharmacy benefit managers, specialty pharmacies and healthcare providers continues to reshape the U.S. drug supply chain, according to a Drug Channels report released April 14. Here are four notes from the report:

The FDA has issued a series of regulatory updates in recent weeks spanning gene therapy, drug approvals, clinical trial oversight and compounding policy, reflecting a broader push to accelerate innovation while tightening compliance. Here are five recent FDA developments: 1.…

The Indiana Board of Pharmacy has rejected a proposed settlement with Muncie, Ind.-based Indiana University Health Ball Memorial Hospital, part of Indianapolis-based Indiana University Health, tied to a drug diversion case, the Indiana Capital Chronicle reported April 14. The agreement…

Hospital and health system leaders say they are placing greater emphasis on real-world experience, clinical judgment and cultural fit when evaluating pharmacist candidates, while standardized exam scores play a minimal role in hiring decisions. The North American Pharmacist Licensure Examination,…

The FDA updated its mifepristone guidance, detailing ongoing work on a safety study and the current status of the drug’s Risk Evaluation and Mitigation Strategy program. According to an April 8 news release, the agency said it is still collecting…

The number of active drug shortages has declined sharply since June, according to the FDA’s database. As of March 19, 76 drugs are in shortage, down from 194 in mid-June. The database is updated daily to reflect manufacturing recoveries, regulatory…

GSK, a biopharmaceutical company, has withdrawn its application to the FDA for leucovorin calcium tablets, months after the White House promoted the drug as a potential treatment for autism-related symptoms, The Wall Street Journal reported April 10.  The FDA approved leucovorin last month to…

Drug shortages in the U.S. remain a persistent challenge for hospitals and pharmacies, even as new shortages fell to a 20-year low in 2025. The American Society of Health-System Pharmacists identified 89 new shortages in 2025, but 216 active shortages…